An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure

Neuropsychopharmacology

Volumn 39, Issue 1, 2014, Pages 88-103

  Stockton, Steven D ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

opioid receptor; addiction; opiate; pain; proteomics; synaptic plasticity

Indexed keywords

BRAIN PROTEIN; CALCIUM ION; CLONIDINE; CYSTEINE STRING PROTEIN; HEAT SHOCK PROTEIN; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUREXIN; OPIATE RECEPTOR; POTASSIUM ION; SYNAPTIC PROTEIN; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT; NERVE PROTEIN;

ANIMAL BEHAVIOR; BRAIN CORTEX; CELL FRACTIONATION; CORPUS STRIATUM; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; ENDOCYTOSIS; FOREBRAIN; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; HYPERPOLARIZATION; LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORPHINE ADDICTION; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PLACE PREFERENCE; POSTSYNAPTIC DENSITY; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE STUDY; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC MEMBRANE; SYNAPTIC TRANSMISSION; SYSTEMATIC REVIEW; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WITHDRAWAL SYNDROME; ANIMAL; BIOLOGICAL MODEL; BRAIN; DRUG EFFECTS; METABOLISM; PROCEDURES;

ANALGESICS, OPIOID; ANIMALS; BRAIN; MODELS, NEUROLOGICAL; MORPHINE; NERVE TISSUE PROTEINS; PROTEOMICS; SYNAPSES; SYSTEMS BIOLOGY;

EID: 84890507787     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.227     Document Type: Review

References (98)

1. Abul-Husn NS, Annangudi SP, Ma'ayan A, Ramos-Ortolaza DL, Stockton SD Jr, Gomes I et al. (2011). Chronic morphine alters the presynaptic protein profile: Identification of novel molecular targets using proteomics and network analysis. PLoS One 6: E25535
2. Abul-Husn NS, Bushlin I, Moró n JA, Jenkins SL, Dolios G, Wang R et al. (2009). Systems approach to explore components and interactions in the presynapse. Proteomics 9: 3303-3315
3. Abul-Husn NS, Devi LA (2006). Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther 318: 461-468
4. Abul-Husn NS, Sutak M, Milne B, Jhamandas K (2007). Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu-And deltaopioid receptor antagonists. Br J Pharmacol 151: 877-887
5. Al-Hasani R, Bruchas MR (2011). Molecular mechanisms of opioid receptordependent signaling and behavior. Anesthesiology 115: 1363-1381
6. Albert R, Barabá si AL (2002). Statistical mechanics of complex networks. Rev Mod Phys 74: 47-97
7. Association AP (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision; DSMIV-TR) Washington, D.C.
8. Barabasi AL, Albert R (1999). Emergence of scaling in random networks. Science 286: 509-512
9. Barabá si AL, Oltvai ZN (2004). Network biology: Understanding the cell's functional organization. Nat Rev Genet 5: 101-113
10. Bayes A, Grant SG (2009). Neuroproteomics: Understanding the molecular organization and complexity of the brain. Nat Rev Neurosci 10: 635-646
11. Berger SI, Posner JM, Ma'ayan A (2007). Genes2Networks: Connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics 8: 372
12. Berland D, Rodgers P (2012). Rational use of opioids for management of chronic nonterminal pain. Am Fam Physician 86: 252-258
13. Brun C, Herrmann C, Gué noche A (2004). Clustering proteins from interaction networks for the prediction of cellular functions. BMC Bioinformatics 5: 95
14. Bu Q, Yang Y, Yan G, Hu Z, Hu C, Duan J et al. (2012). Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. J Proteomics 75: 1330-1342
15. Calignano A, Moncada S, Di Rosa M (1991). Endogenous nitric oxide modulates morphine-induced constipation. Biochem Biophys Res Commun 181: 889-893
16. Carlin RK, Grab DJ, Cohen RS, Siekevitz P (1980). Isolation and characterization of postsynaptic densities from various brain regions: Enrichment of different types of postsynaptic densities. J Cell Biol 86: 831-845
17. Chao J, Nestler EJ (2004). Molecular neurobiology of drug addiction. Annu Rev Med 55: 113-132
18. Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM et al. (2006). Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics 5: 1158-1170
19. Cho KO, Hunt CA, Kennedy MB (1992). The rat brain postsynaptic density fraction contains a homolog of the Drosophila disc-large tumor suppressor protein. Neuron 9: 929-942
20. Cohen RS, Blomberg F, Berzins K, Siekevitz P (1977). The structure of postsynaptic densities isolated from dog cerebral cortex. I. Overall morphology and protein composition. J Cell Biol 74: 181-203
21. Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP et al. (2006). Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 97: 16-23
22. Cotman CW, Banker G, Churchill L, Taylor D (1974). Isolation of postsynaptic densities from rat brain. J Cell Biol 63: 441-455
23. Dosemeci A, Tao-Cheng JH, Vinade L, Jaffe H (2006). Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem Biophys Res Commun 339: 687-694
24. Duman RS, Tallman JF, Nestler EJ (1988). Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus coeruleus. J Pharmacol Exp Ther 246: 1033-1039
25. Faber ES, Sah P (2004). Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current. J Neurosci 24: 3031-3039
26. Farrell M (1994). Opiate withdrawal. Addiction 89: 1471-1475
27. Fernandez E, Collins MO, Uren RT, Kopanitsa MV, Komiyama NH, Croning MD et al. (2009). Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol Syst Biol 5: 269
28. Fioravante D, Liu RY, Byrne JH (2008). The ubiquitin-proteasome system is necessary for long-Term synaptic depression in Aplysia. J Neurosci 28: 10245-10256
29. Granados-Soto V, Kalcheva I, Hua X, Newton A, Yaksh TL (2000). Spinal PKC activity and expression: Role in tolerance produced by continuous spinal morphine infusion. Pain 85: 395-404
30. Grant SG (2003). Synapse signalling complexes and networks: Machines underlying cognition. BioEssays 25: 1229-1235
31. Hajó s F (1975). An improved method for the preparation of synaptosomal fractions in high purity. Brain Res 93: 485-489
32. Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999). From molecular to modular cell biology. Nature 402: C47-C52
33. Hegde AN, Goldberg AL, Schwartz JH (1993). Regulatory subunits of cAMPdependent protein kinases are degraded after conjugation to ubiquitin: A molecular mechanism underlying long-Term synaptic plasticity. Proc Natl Acad Sci USA 90: 7436-7440
34. Hsia JA, Moss J, Hewlett EL, Vaughan M (1984). ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem 259: 1086-1090
35. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG (2000). Proteomic analysis of NMDA receptor-Adhesion protein signaling complexes. Nat Neurosci 3: 661-669
36. Jenkins SL, Ma'ayan A (2013). Systems pharmacology meets predictive, preventive, personalized and participatory medicine. Pharmacogenomics 14: 119-122
37. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabá si AL (2000). The large-scale organization of metabolic networks. Nature 407: 651-654
38. Jordan BA, Devi LA (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399: 697-700
39. Jordan BA, Fernholz BD, Boussac M, Xu C, Grigorean G, Ziff EB et al. (2004). Identification and verification of novel rodent postsynaptic density proteins. Mol Cell Proteomics 3: 857-871
40. Kelly PT, McGuinness TL, Greengard P (1984). Evidence that the major postsynaptic density protein is a component of a Ca2/calmodulin-dependent protein kinase. Proc Natl Acad Sci USA 81: 945-949
41. Kennedy MB, Bennett MK, Erondu NE (1983). Biochemical and immunochemical evidence that the 'major postsynaptic density protein' is a subunit of a calmodulin-dependent protein kinase. Proc Natl Acad Sci USA 80: 7357-7361
42. Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ (2004). Neuroproteomics: Expression profiling of the brain's proteomes in health and disease. Neurochem Res 29: 1317-1331
43. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ et al. (2004). Proteomic analysis of phosphotyrosyl proteins in the rat brain: Effect of butorphanol dependence. J Neurosci Res 77: 867-877
44. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ et al. (2005). Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 133: 58-70
45. Klemmer P, Smit AB, Li KW (2009). Proteomics analysis of immuno-precipitated synaptic protein complexes. J Proteomics 72: 82-90
46. Law PY, Wong YH, Loh HH (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389-430
47. Li KW, Hornshaw MP, Van Der Schors RC, Watson R, Tate S, Casetta B et al. (2004). Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem 279: 987-1002
48. Li KW, Jimenez CR, van der Schors RC, Hornshaw MP, Schoffelmeer AN, Smit AB (2006). Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 6: 2003-2008
49. Li Q, Zhao X, Zhong LJ, Yang HY, Wang Q, Pu XP (2009). Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur J Pharmacol 612: 21-28
50. Li Y, Kolb B, Robinson TE (2003). The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 28: 1082-1085
51. Lin X, Wang Q, Cheng Y, Ji J, Yu LC (2011). Changes of protein expression profiles in the amygdala during the process of morphine-induced conditioned place preference in rats. Behav Brain Res 221: 197-206
52. Lovinger DM (2010). Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58: 951-961
53. Lovinger DM, Partridge JG, Tang KC (2003). Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse. Ann NY Acad Sci 1003: 226-240
54. Ma'ayan A, Jenkins SL, Neves S, Hasseldine A, Grace E, Dubin-Thaler B et al. (2005). Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science 309: 1078-1083
55. Meyer U (2008). The history of antitussive and expectorants. Pharm Unserer Zeit 37: 450-456
56. Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U (2002). Network motifs: Simple building blocks of complex networks. Science 298: 824-827
57. Minneman KP, Iversen IL (1976). Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature 262: 313-314
58. Moron JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA (2007). Morphine administration alters the profile of hippocampal postsynaptic densityassociated proteins: A proteomics study focusing on endocytic proteins. Mol Cell Proteomics 6: 29-42
59. Nestler EJ (1996). Under siege: The brain on opiates. Neuron 16: 897-900
60. Nestler EJ (2001). Molecular basis of long-Term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128
61. Nestler EJ (2004). Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25: 210-218
62. Okada K, Kanaya S, Asai K (2005). Accurate extraction of functional associations between proteins based on common interaction partners and common domains. Bioinformatics 21: 2043-2048
63. Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC et al. (2009). A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res 8: 3752-3759
64. Peng J, Kim MJ, Cheng D, Duong DM, Gygi Sp, Sheng M (2004). Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem 279: 21003-21011
65. Phillips GR, Huang JK, Wang Y, Tanaka H, Shapiro L, Zhang W (2001). The presynaptic particle web: Ultrastructure, composition, dissolution and reconstitution. Neuron 32: 63-77
66. Phillips GR, Florens L, Tanaka H, Khaing ZZ, Fidler L, Yates JR 3rd et al. (2005). Proteomic comparison of two fractions derived from the transsynaptic scaffold. J Neurosci Res 81: 762-775
67. Pocklington AJ, Cumiskey M, Armstrong JD, Grant SG (2006). The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol Syst Biol 2: 2006.0023
68. Prokai L, Zharikova AD, Stevens SM Jr (2005). Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: A quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/ mass spectrometry. J Mass Spectrom 40: 169-175
69. Ramos-Ortolaza DL, Bushlin I, Abul-Husn N, Annangudi SP, Sweedler J, Devi LA (2010). Quantitative neuroproteomics of the synapse. Methods Mol Biol 615: 227-246
70. Robinson TE, Kolb B (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497
71. Robinson TE, Kolb B (1999). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11: 1598-1604
72. Robinson TE, Kolb B (1999). Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33: 160-162
73. Robinson TE, Kolb B (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47: 33-46
74. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ (2010). The addicted synapse: Mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 33: 267-276
75. Samanta MP, Liang S (2003). Predicting protein functions from redundancies in large-scale protein interaction networks. Proc Natl Acad Sci USA 100: 12579-12583
76. Satoh K, Takeuchi M, Oda Y, Deguchi-Tawarada M, Sakamoto Y, Matsubara K et al. (2002). Identification of activity-regulated proteins in the postsynaptic density fraction. Genes Cells 7: 187-197
77. Schrimpf SP, Meskenaite V, Brunner E, Rutishauser D, Walther P, Eng J et al. (2005). Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics 5: 2531-2541
78. Sharan R, Ulitsky I, Shamir R (2007). Network-based prediction of protein function. Mol Sys Biol 3: 88
79. Shui HA, Ho ST, Wang JJ, Wu CC, Lin CH, Tao YX et al. (2007). Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection. Proteomics 7: 796-803
80. Song Z, Guo Q, Zhang J, Li M, Liu C, Zou W (2012). Proteomic analysis of PKCgamma-related proteins in the spinal cord of morphine-Tolerant rats. PLoS One 7: E42068
81. Spirin V, Mirny LA (2003). Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci USA 100: 12123-12128
82. Stevens SM Jr, Zharikova AD, Prokai L (2003). Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain. Brain Res Mol Brain Res 117: 116-128
83. Suder P, Bodzon-Kulakowska A, Mak P, Bierczynska-Krzysik A, Daszykowski M, Walczak B et al. (2009). The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J Proteome Res 8: 4633-4640
84. Tan R, Zou D, Chang Y (2010). Proteomic analysis of morphine rabbit myocardium with matrix-Assisted laser desorption/ionization time-offlight mass spectrometry. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35: 607-611
85. Taussig R, Iniguez-Lluhi JA, GIlman AG (1993). Inhibition of adenylyl cyclase by Gi alpha. Science 261: 218-221
86. Taylor IW, Wrana JL (2012). Protein interaction networks in medicine and disease. Proteomics 12: 1706-1716
87. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548: 100-110
88. Wagner A, Fell DA (2001). The small world inside large metabolic networks. Proc Biol Sci 268: 1803-1810
89. Walikonis RS, Jensen ON, Mann M, Provance DW Jr, Mercer JA, Kennedy MB (2000). Identification of proteins in the postsynaptic density fraction by mass spectrometry. J Neurosci 20: 4069-4080
90. Wang XJ, Yu J, Wong SH, Cheng AS, Chan FK, Ng SS et al. (2013). A novel crosstalk between two major protein degradation systems: Regulational of proteasomal activity by autophagy. Autophagy 11, (e-pub ahead of print
91. Watts DJ, Strogatz SH (1998). Collective dynamics of 'small-world' networks. Nature 393: 440-442
92. Wei QH, Wu N, Bian JM, Chen Y, Su RB, Li J (2013). Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal. Addict Biol 18: 230-240
93. Wolters DA, Washburn MP, Yates JR 3rd (2001). An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73: 5683-5690
94. Wu K, Carlin R, Siekevitz P (1986). Binding of L-[3H]glutamate to fresh and frozen synaptic membrane and postsynaptic density fractions isolated from cerebral cortex and cerebellum of fresh or frozen canine brain. J Neurochem 46: 831-841
95. Yang L, Sun ZS, Zhu YP (2007). Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 6: 2239-2247
96. Yoshimura Y, Yamauchi T (1997). Phosphorylation-dependent revesible association of Ca+2/calmodulin-dependent protein kinase II with the postsynaptic densities. J Biol Chem 272: 26354-26359
97. Yoshimura Y, Yamauchi Y, Shinkawa T, Taoka M, Donai H, Takahashi N et al. (2004). Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-Tandem mass spectrometry. J Neurochem 88: 759-768
98. Zeitz KP, Malmberg AB, Gilbert H, Basbaum AI (2001). Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice. Pain 94: 245-253